ATE466025T1 - Physiologisch aktive peptide und medikamente, die diese enthalten - Google Patents
Physiologisch aktive peptide und medikamente, die diese enthaltenInfo
- Publication number
- ATE466025T1 ATE466025T1 AT04713248T AT04713248T ATE466025T1 AT E466025 T1 ATE466025 T1 AT E466025T1 AT 04713248 T AT04713248 T AT 04713248T AT 04713248 T AT04713248 T AT 04713248T AT E466025 T1 ATE466025 T1 AT E466025T1
- Authority
- AT
- Austria
- Prior art keywords
- physiologically active
- seq
- peptide
- amino acid
- active peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003045166 | 2003-02-21 | ||
JP2003142845A JP2004307454A (ja) | 2003-02-21 | 2003-05-21 | 生理活性ペプチド及びこれを含有する薬剤 |
PCT/JP2004/002009 WO2004074319A1 (ja) | 2003-02-21 | 2004-02-20 | 生理活性ペプチド及びこれを含有する薬剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE466025T1 true ATE466025T1 (de) | 2010-05-15 |
Family
ID=32911432
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04713248T ATE466025T1 (de) | 2003-02-21 | 2004-02-20 | Physiologisch aktive peptide und medikamente, die diese enthalten |
AT08006914T ATE529440T1 (de) | 2003-02-21 | 2004-02-20 | Biologisch aktives peptid und wirkstoff, der dieses enthält |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08006914T ATE529440T1 (de) | 2003-02-21 | 2004-02-20 | Biologisch aktives peptid und wirkstoff, der dieses enthält |
Country Status (7)
Country | Link |
---|---|
US (2) | US7365153B2 (de) |
EP (2) | EP2000478B1 (de) |
JP (3) | JP2004307454A (de) |
AT (2) | ATE466025T1 (de) |
DE (1) | DE602004026840D1 (de) |
ES (2) | ES2378711T3 (de) |
WO (1) | WO2004074319A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004307454A (ja) * | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
US8707326B2 (en) * | 2012-07-17 | 2014-04-22 | Concurix Corporation | Pattern matching process scheduler in message passing environment |
US9575813B2 (en) | 2012-07-17 | 2017-02-21 | Microsoft Technology Licensing, Llc | Pattern matching process scheduler with upstream optimization |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6300062B1 (en) | 1995-07-13 | 2001-10-09 | Biora Ab | Enamel matrix related polypeptide |
JPH11510377A (ja) | 1995-07-13 | 1999-09-14 | バイオラ エイビー | エナメル質マトリックス関連ポリペプチド |
US20010039335A1 (en) * | 1997-04-10 | 2001-11-08 | Kenneth Jacobs | Secreted proteins and polynucleotides encoding them |
CA2316973A1 (en) | 1998-01-07 | 1999-07-15 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
CA2322215C (en) * | 1998-02-27 | 2010-12-21 | Biora Bioex Ab | Matrix protein compositions for wound healing |
RU2241489C2 (ru) * | 1998-02-27 | 2004-12-10 | Биора Биоэкс Аб | Композиции матриксных протеинов для залечивания ран |
ES2215028T3 (es) * | 1999-03-10 | 2004-10-01 | Biora Bioex Ab | Composiciones de proteinas de matrices destinadas para el injertado en tejidos no mineralizados. |
CN1302883A (zh) * | 1999-10-29 | 2001-07-11 | 上海博道基因技术有限公司 | 一种新的多肽——人成釉质蛋白23和编码这种多肽的多核苷酸 |
JP2004307454A (ja) * | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
-
2003
- 2003-05-21 JP JP2003142845A patent/JP2004307454A/ja active Pending
-
2004
- 2004-02-20 EP EP08006914A patent/EP2000478B1/de not_active Expired - Lifetime
- 2004-02-20 DE DE602004026840T patent/DE602004026840D1/de not_active Expired - Lifetime
- 2004-02-20 AT AT04713248T patent/ATE466025T1/de not_active IP Right Cessation
- 2004-02-20 EP EP04713248A patent/EP1602665B1/de not_active Expired - Lifetime
- 2004-02-20 US US10/546,223 patent/US7365153B2/en not_active Expired - Fee Related
- 2004-02-20 AT AT08006914T patent/ATE529440T1/de not_active IP Right Cessation
- 2004-02-20 ES ES08006914T patent/ES2378711T3/es not_active Expired - Lifetime
- 2004-02-20 WO PCT/JP2004/002009 patent/WO2004074319A1/ja active Application Filing
- 2004-02-20 ES ES04713248T patent/ES2347245T3/es not_active Expired - Lifetime
- 2004-02-20 JP JP2005502796A patent/JP4630816B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-20 US US12/052,578 patent/US7678884B2/en not_active Expired - Fee Related
-
2010
- 2010-03-23 JP JP2010066733A patent/JP5047323B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2004074319A1 (ja) | 2004-09-02 |
US20060172947A1 (en) | 2006-08-03 |
US20090137482A1 (en) | 2009-05-28 |
EP2000478A1 (de) | 2008-12-10 |
JPWO2004074319A1 (ja) | 2006-06-01 |
JP2010189399A (ja) | 2010-09-02 |
US7678884B2 (en) | 2010-03-16 |
JP5047323B2 (ja) | 2012-10-10 |
ES2347245T3 (es) | 2010-10-27 |
US7365153B2 (en) | 2008-04-29 |
DE602004026840D1 (de) | 2010-06-10 |
JP2004307454A (ja) | 2004-11-04 |
EP1602665B1 (de) | 2010-04-28 |
EP2000478B1 (de) | 2011-10-19 |
JP4630816B2 (ja) | 2011-02-09 |
ATE529440T1 (de) | 2011-11-15 |
EP1602665A4 (de) | 2007-07-18 |
EP1602665A1 (de) | 2005-12-07 |
ES2378711T3 (es) | 2012-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0111718A (pt) | Peptìdeos quimicamente modificados, composições e métodos de produção e uso | |
CL2003001743A1 (es) | Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida | |
ATE363535T1 (de) | Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend | |
ATE364698T1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
ATE496060T1 (de) | Proteinartige verbindungen und anwendungen davon | |
IL150223A (en) | Lipopeptides and pharmaceuticals containing them | |
ATE430165T1 (de) | Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten | |
EP1940872A4 (de) | Peptide, die bei der linderung von hautleiden oder der behandlung von periodentalkrankheiten wirkung zeigen | |
UA91820C2 (ru) | Терапевтическое применение вариантов хемокинов | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
DE602004019528D1 (de) | Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
ATE466025T1 (de) | Physiologisch aktive peptide und medikamente, die diese enthalten | |
RU2002135669A (ru) | Олигопептиды | |
ATE193305T1 (de) | Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen | |
DE69131355D1 (de) | Die knochenresorption hemmende verbindungen und zusammensetzungen | |
DE69333351D1 (de) | Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen | |
ATE353912T1 (de) | Peptizusammensetzung für die mundhöhle | |
ATE371737T1 (de) | Proteaseresistente flint-analoge | |
DE60329115D1 (de) | Tumorantigenprotein und dessen verwendung | |
NO20052525L (no) | Spleisevariant av humant hypofyseveksthormon | |
HUP0400667A2 (hu) | Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására | |
WO2003066849A3 (en) | Novel purified polypeptides from staphylococcus aureus | |
WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
IT1307866B1 (it) | Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento | |
MXPA05003912A (es) | Celula transplantable con modulador inmune. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |